Hide Board Information

Show Board Information

Cytosorbents Corp CTSO

Board Mod: Add me as mod

Asst Mods: SABAI4SABAI

Last Post: 12/13/2023 12:55:45 PM

Board Marks: 3

Posts Today: 0

Board Views Today: 71

Cytosorbents Corp. (NASDAQ: CTSO)

Company Website: http://www.cytosorbents.com/

Cytosorbents Corp (NASDAQ: CTSO) Stock Message Board

1. CTSO Company Profile

    

2. CTSO Time & Sales

    

3. CTSO Recent News

    

4. CTSO Filings

    

5. CTSO Financials

    

6. CTSO Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

4	It's alive!	Dynabolic	04/05/2013 1:01:07 PM
3	10k out:	fity4fity	04/03/2013 9:04:24 AM
2	Like the recent news, buy and hold here	Dynabolic	03/26/2013 10:43:03 AM
1	Here are some news bits for those new to CTSO:	fity4fity	02/17/2013 10:21:25 AM

Newer

Recent Articles

• Fidelity D & D Bancorp Declares Q2 2025 Dividend Payment
• Teamsters at Seattle Airport Vote to Strike Against Swissport
• Empowering Tomorrow's Real Estate Leaders Through Education
• California's Bill AB 446 Aims to Protect Consumers from Pricing Abuse
• Veltex Corporation Expands Board with New Strategic Leaders
• Bellroy Unveils Innovative Luggage Solutions for Travel Enthusiasts
• Propelis Emerges as a Major Brand Agency Powerhouse
• MPLX and Enbridge Join Forces on Matterhorn Express Pipeline
• Edgewood Monuments Expands Custom Memorial Services Across USA
• Allied Properties' Latest Unitholder Meeting Unveils Key Decisions
• Insightful Analysis of Overspending in Police Overtime
• Investigation Launched for Investors of Take-Two Software
• Adcentrx Therapeutics Accelerates Development of ADRX-0706
• Montage Gold Expands Influence in Côte d’Ivoire Gold Sector
• Osisko Development's Q1 2025 Results: Growth and Progress Insights
• Ardelyx, Inc. Faces Investigation After Financial Shortfall
• Veterans' Impact Highlighted at Washington Hearing with Independence Fund
• Integra LifeSciences Faces Investigation Over Financial Discrepancies
• Investigation of PTC Therapeutics: Examining Investor Claims
• Strong Performance Declared by IRSA for Third Quarter 2025
• Passenger Traffic Growth Soars for Grupo Aeroportuario del Pacífico
• Western Forest Products Reports Strong Q1 2025 Growth
• Formosa Pharmaceuticals Expands Licensing for Innovative Eye Treatment
• Apotex Expands Licensing Agreement for Innovative Ophthalmic Medicine
• Blinq Secures $25 Million Funding to Revolutionize Networking
• Investors Urged to Act: Security Fraud Class Action on WST
• Tenaris Shareholders Approve All Resolutions at Annual Meeting
• Investigation of Cytokinetics: Understanding Your Rights
• Salmonella Outbreak Leads to Lawsuit Against Mediterranean Café
• Curis, Inc. Announces Key Stock Options for Leadership
• Allegations of Tax Authority Misconduct Spark Outcry in Spain
• Southwest Gas Holdings Announces Updated Earnings Call Schedule
• OpenSearch 3.0 Revolutionizes Vector Database Capabilities and Performance
• NASA+ Launches New Channel on Prime Video for Exploration
• Investors May Play a Key Role in West Pharmaceutical Class Action
• Eupraxia Pharmaceuticals Reveals Positive Financial Outcomes
• Dogecoin Cash, Inc. Announces Details of Upcoming Dividend Payments
• NOVAGOLD Plans Major Share Offering to Fund Strategic Growth
• PhenixFIN Corporation Reports Strong Q2 Performance Amid Market Fluctuations
• ION Launches Exciting Coverage for WNBA Season's Games
• SURA Asset Management S.A. Announces Tender Offer for Notes
• YUTIQ's Role in Transforming Uveitis Treatment Landscape
• Boardwalk REIT's Q1 Performance Shows Growth and Resilience
• RGC Resources Reports Impressive Growth in Recent Earnings
• Ashland Inc. Boosts Shareholder Value with Dividend Increase
• Firm Capital Mortgage Investment Corporation Reports Strong Q1 Results
• PHX Energy Reports Record Revenue with Solid Yearly Growth
• Midland States Bancorp, Inc. Declares Stock Dividends for Investors
• WeightWatchers Reduces Debt and Strengthens Future Growth Path
• TrueLark's Acquisition by Weave: A New Chapter for AI in Business